iSpecimen shares surged more than 100% in premarket trading while the stock rose 80.49% on last day.
iSpecimen Inc., an online marketplace for human biospecimens, yesterday announced that it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments. In the last ten months, the company has partnered with multiple research and health care organizations on a range of diverse projects requiring a variety of COVID-19 samples, including nasal swabs, saliva, and blood products.